Pacira BioSciences, Inc. PCRX
36.46 USD 0.00 (+0.00%)
Regular-session close
36.46 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
36.43 Day range 36.48
18.80 52-week range 36.67
- YTD
- +40.88%
- 1 year
- +54.36%
News
prnewswire.com Ingram Micro Holding Set to Join S&P SmallCap 600 NEW YORK, Nov. 11, 2026 /PRNewswire/ -- Ingram Micro Holding Corp. (NYSE: INGM) will replace Pacira BioSciences Inc. (NASD: PCRX) in the S&P SmallCap 600 effective prior to the opening of trading on…benzinga.com Ingram Micro To Replace Pacira Biosciences In the S&P SmallCap 600 Effective Prior To The Opening Of Trading On Tuesday, November 17 https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20261111-1485671/1485671_pcrx6.pdf
fool.com Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT? One fund holds about 60 drug companies at a lower fee. The other holds 30 biotech names and has a stronger long-term record. Either way, expect some volatility.benzinga.com Pacira BioSciences Withdraws 2026 Guidance Pending Proposed Merger With Viatris As previously disclosed, on October 8, 2026, Pacira BioSciences, Inc., a Delaware corporation (the "Company" or "Pacira"), entered into the Agreement and Plan of Merger (the "Merger Agreement")
benzinga.com Viatris Subsidiary Peach Purchaser Sub Commences Tender Offer To Acquire Pacira Biosciences For $36.50/Shr Viatris Inc. ("Viatris") (NASDAQ:VTRS), a global healthcare company, today announced that Peach Purchaser Sub Inc. ("Purchaser"), a wholly owned subsidiary of Viatris, has commenced a tender offer to
benzinga.com Top 3 Health Care Stocks That May Fall Off A Cliff In October Option Care Health, Pacira Biosciences and HealthStream show overbought RSI levels above 83, warning momentum-focused investors.
